Tenet Healthcare Corporation company logo

# 1st Gen Model Tenet Healthcare Corporation General medical & surgical hospitals

64.79% successful of 71 deals
$14.34 Last close price
at 15-dec-2017

THC

Model's trade recommendations 7.77% Return for period

-8.67% Annual return

$1.50B Market Cap

β 1.17  

THC

Model (following trade recommendations)

THC

Underlying stock

S&P 500

Index
Return for period 7.77%
8.31%
1.78%
52wk return 3.46%
-5.22%
16.82%
52wk Range
12.65—22.67
2000.54—2399.63
Sortino ratio -0.26
Sharpe ratio -0.22
Norm. RMSE 0.65%
Downside risk 22.39%
Volatility 26.40%
  • BUY Analysts consensus recommendation

Tenet Healthcare Corporation is a multinational investor-owned healthcare services company. At Tenet Healthcare, they have a longstanding commitment to serving patients, employees, physicians and partners. Tenet's Conifer Health Solutions subsidiary provides technology-enabled performance improvement and health management solutions to hospitals, health systems, integrated delivery networks, physician groups, self-insured organizations and health plans. Across their network of medical facilities, the Company's employees provide compassionate, quality care to millions of patients through a wide range of services: from wellness and primary care to chronic care management, urgent care, outpatient surgery, advanced diagnostics, rehabilitation and acute hospital care.

Industry sector: Medical

Sector classification: General medical & surgical hospitals

Deep Learning based analysis and prediction model for Tenet Healthcare Corporation (THC) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for THC model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 98M
P/E NaN
Shares Outstanding 101M
% Held by Insiders 3.10%
% Held by Institutions NaN%
EPS (last reported FY) $1.04
EPS (last reported Q) $-0.17
EPS, estimated (last reported Q) $-0.38
Total revenues $20 B
Net income $-0 B